These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1608 related items for PubMed ID: 18722321

  • 21. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 22. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S.
    Curr Med Res Opin; 2001 Sep 02; 17(4):290-7. PubMed ID: 11922403
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG, Duong T, Bland JM, Malik M, Torp-Pederson C, Køber L, Connolly SJ, Gallagher MM, Camm AJ.
    J Hypertens; 2007 Feb 02; 25(2):307-13. PubMed ID: 17211237
    [Abstract] [Full Text] [Related]

  • 24. The association between blood pressure and mortality in patients with heart failure.
    Lee TT, Chen J, Cohen DJ, Tsao L.
    Am Heart J; 2006 Jan 02; 151(1):76-83. PubMed ID: 16368295
    [Abstract] [Full Text] [Related]

  • 25. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]).
    Domanski M, Coady S, Fleg J, Tian X, Sachdev V.
    Am J Cardiol; 2007 May 15; 99(10):1448-50. PubMed ID: 17493477
    [Abstract] [Full Text] [Related]

  • 26. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I, Zareba W, Vazquez R, Bayes-Genis A, Pascual D, Macaya C, Almendral J, Fiol M, Bardaji A, Gonzalez-Juanatey JR, Nieto V, Valdes M, Cinca J, de Luna AB, MUSIC Investigators.
    Am J Cardiol; 2009 Apr 01; 103(7):1003-10. PubMed ID: 19327431
    [Abstract] [Full Text] [Related]

  • 27. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D, Peltier M, Cohen-Solal A, Béguin M, Lévy F, Slama M, Chapelain K, Tribouilloy C.
    Int J Cardiol; 2005 Sep 01; 103(3):286-92. PubMed ID: 16098391
    [Abstract] [Full Text] [Related]

  • 28. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec 01; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 29. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP, Vaduganathan M, Mentz RJ, Greene SJ, Subačius H, Konstam MA, Maggioni AP, Swedberg K, Gheorghiade M.
    Am Heart J; 2013 Feb 01; 165(2):216-25. PubMed ID: 23351825
    [Abstract] [Full Text] [Related]

  • 30. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S, Manchanda SC.
    Indian Heart J; 2003 Feb 01; 55(2):167-71. PubMed ID: 12921333
    [Abstract] [Full Text] [Related]

  • 31. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.
    Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT, Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) Study Group.
    Circulation; 2010 Mar 09; 121(9):1086-95. PubMed ID: 20176990
    [Abstract] [Full Text] [Related]

  • 32. Postprandial hypotension predicts all-cause mortality in older, low-level care residents.
    Fisher AA, Davis MW, Srikusalanukul W, Budge MM.
    J Am Geriatr Soc; 2005 Aug 09; 53(8):1313-20. PubMed ID: 16078956
    [Abstract] [Full Text] [Related]

  • 33. Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?
    Mak G, Murphy NF, Ali A, Walsh A, O'Loughlin C, Conlon C, McCaffrey D, Ledwidge M, McDonald K.
    J Card Fail; 2008 Sep 09; 14(7):555-60. PubMed ID: 18722320
    [Abstract] [Full Text] [Related]

  • 34. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study.
    Piccirillo G, Magrì D, Matera S, Magnanti M, Torrini A, Pasquazzi E, Schifano E, Velitti S, Marigliano V, Quaglione R, Barillà F.
    Eur Heart J; 2007 Jun 09; 28(11):1344-50. PubMed ID: 17101636
    [Abstract] [Full Text] [Related]

  • 35. Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.
    Lee DS, Ghosh N, Floras JS, Newton GE, Austin PC, Wang X, Liu PP, Stukel TA, Tu JV.
    Circ Heart Fail; 2009 Nov 09; 2(6):616-23. PubMed ID: 19919987
    [Abstract] [Full Text] [Related]

  • 36. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 09; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

  • 37. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A, Aronow WS, Vadnerkar A, Sivan K, Mittal S.
    Am J Ther; 2009 Feb 09; 16(1):5-7. PubMed ID: 19142162
    [Abstract] [Full Text] [Related]

  • 38. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O, Cuevas G, Bunout D.
    Rev Med Chil; 1998 Jul 09; 126(7):745-52. PubMed ID: 9830766
    [Abstract] [Full Text] [Related]

  • 39. Non-invasive blood pressure variability in chronic heart failure: characteristics and prognostic value.
    Gibelin P, Spillner E, Bonnan S, Chevallier T.
    Arch Mal Coeur Vaiss; 2003 Oct 09; 96(10):955-62. PubMed ID: 14653055
    [Abstract] [Full Text] [Related]

  • 40. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.
    Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 81.